Organogenesis Holdings (ORGO) Operating Leases (2021 - 2026)

Organogenesis Holdings' Operating Leases history runs 6 years deep, the most recent figure standing at $21.8 million for Q1 2026.

• In Q1 2026, Operating Leases fell 14.98% year-over-year to $21.8 million; the TTM figure through Mar 2026 stood at $21.8 million (down 14.98% YoY), while the FY2025 annual figure was $22.5 million, down 10.83% from the prior year.
• Operating Leases was $21.8 million for Q1 2026 at Organogenesis Holdings, down from $22.5 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $45.3 million in Q1 2022 to a low of $20.9 million in Q4 2022.
• Historically, Operating Leases has averaged $30.1 million across 5 years, with a median of $25.1 million in 2023.
• Biggest YoY gain for Operating Leases was 80.4% in 2022; the steepest drop was 55.33% in 2022.
• A 5-year view of Operating Leases shows it stood at $20.9 million in 2022, then increased by 19.6% to $25.1 million in 2023, then climbed by 0.58% to $25.2 million in 2024, then decreased by 10.83% to $22.5 million in 2025, then declined by 3.04% to $21.8 million in 2026.
• The last three Operating Leases figures came in at $21.8 million (Q1 2026), $22.5 million (Q4 2025), and $23.5 million (Q3 2025), per Business Quant data.